The quality assurance unit of ZistDaru Danesh Company emphasizes planning, documenting, and implementing the necessary guidelines for quality assurance.

This process begins at the start of the project to identify the requirements and needs of the products and to fulfill them according to national and international guidelines and laws.

• Opening new avenues in dermatological products

• Being recognized as the most successful and popular pharmaceutical brand in the field of specific diseases in Iran and the neighboring countries

• Receiving European GMP certification

ZISTDARU, relying on modern technology and global knowledge, produces medicines for specific diseases to create a sense of support and empathy for specific patients. Founded in 2004, ZISTDARU DANESH is a private, knowledge-based conglomerate at the forefront of chemical and biological medicinal product development and marketing. With its inception at the growth center of Tehran University of Medical Sciences’ technological units, the company has been a beacon of innovation from the very start.

In 2013, the company embarked on an ambitious project to construct a state-of-the-art pharmaceutical production facility in Baharestan Karaj Industrial City. By 2015, this facility became the birthplace of Zifron and Tebazio products, marking a new era of pharmaceutical manufacturing for the company.

Today, ZISTDARU DANESH boasts four specialized production lines:

1. Recombinant Protein Production using bacterial systems.
2. Monoclonal Antibody Production for targeted therapies.
3. Vial Filling and Lyophilization for preserving pharmaceuticals.
4. High-Risk Drug Manufacturing ensuring safety and quality.

The company’s portfolio includes a diverse range of bio-pharmaceuticals designed to combat multiple sclerosis (MS), various cancers, and rare diseases. These products not only satisfy domestic pharmaceutical demands but also reach international markets, showcasing the company’s global impact.

ZISTDARU DANESH has also taken significant strides in contract production, particularly for high-risk drugs and lyophilized vial formulations, further cementing its role as a pivotal player in the pharmaceutical industry.

At the heart of ZISTDARU DANESH’s mission is a commitment to environmental stewardship, social responsibility, and cultural sensitivity. The company strives to innovate and collaborate, drawing on collective wisdom to alleviate suffering and enhance the quality of life for humanity. It believes that understanding one’s mission is essential to defining purpose, and without this knowledge, efforts are futile.

ZISTDARU DANESH stands as a testament to progress, with a vision to pass on a more beautiful world to future generations. It is a company that not only manufactures medicines but also aims to heal the world—one innovation at a time.